Abivax SA (ABVX)
124.10
+4.20
(+3.50%)
USD |
NASDAQ |
May 21, 16:00
124.29
+0.19
(+0.15%)
After-Hours: 19:59
Abivax Market Cap : 9.825B for May 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 1.022B |
| Nicox SA | 30.94M |
| Cellectis SA | 357.17M |
| Transgene SA | 112.45M |
| Innate Pharma SA | 187.61M |
Market Cap Related Metrics
| Price to Book Value | 18.38 |
| Price | 124.10 |
| Earnings Yield | -4.36% |